Hyperpolarized Helium-3
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Massachusetts, Worcester
Overview
Hyperpolarized Helium-3 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Hyperpolarized Helium-3 clinical trials
Explore related
Medical disclaimer. This page summarizes research about Hyperpolarized Helium-3 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.